Filing metadata

Accession number
0001104659-19-046858
Form type
Form 4
Filer
Nabriva Therapeutics plc
CIK
CIK 1641640
Filed
Aug 21, 2019
Reporting period
Aug 19, 2019
Description
Insider transaction

Explore SEC Filings Hub